-
1
-
-
0038664368
-
Kava: herbal panacea or liver poison?
-
Moulds R.F.W., Malani J. Kava: herbal panacea or liver poison?. Med J Aust 2003, 178:451-453.
-
(2003)
Med J Aust
, vol.178
, pp. 451-453
-
-
Moulds, R.F.W.1
Malani, J.2
-
2
-
-
0038399798
-
Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use?
-
Currie B.J., Clough A.R. Kava hepatotoxicity with Western herbal products: does it occur with traditional kava use?. Med J Aust 2003, 178:421-422.
-
(2003)
Med J Aust
, vol.178
, pp. 421-422
-
-
Currie, B.J.1
Clough, A.R.2
-
4
-
-
0037532579
-
Kava extracts: safety and risks including rare hepatotoxicity
-
Teschke R., Gaus W., Loew D. Kava extracts: safety and risks including rare hepatotoxicity. Phytomedicine 2003, 10:440-446.
-
(2003)
Phytomedicine
, vol.10
, pp. 440-446
-
-
Teschke, R.1
Gaus, W.2
Loew, D.3
-
5
-
-
0038249051
-
Toxicity of kava pyrones, drug safety and precautions - a case study
-
Schulze J., Raasch W., Siegers C.P. Toxicity of kava pyrones, drug safety and precautions - a case study. Phytomedicine 2003, 10(Suppl IV):68-73.
-
(2003)
Phytomedicine
, vol.10
, Issue.SUPPL. IV
, pp. 68-73
-
-
Schulze, J.1
Raasch, W.2
Siegers, C.P.3
-
6
-
-
38849140694
-
Kava: a risk-benefit assessment
-
Elsevier Churchill Livingstone, St. Louis (Missouri), M. Mills, K. Bone (Eds.)
-
Schmidt M., Morgan M., Bone K., McMillan J. Kava: a risk-benefit assessment. The essential guide to herbal safety 2005, 155-221. Elsevier Churchill Livingstone, St. Louis (Missouri). M. Mills, K. Bone (Eds.).
-
(2005)
The essential guide to herbal safety
, pp. 155-221
-
-
Schmidt, M.1
Morgan, M.2
Bone, K.3
McMillan, J.4
-
7
-
-
78751566523
-
Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?
-
Teschke R., Wolff A. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?. Reg Toxicol Pharmacol 2010, 10.1016/j.yrtph.2010.09.006.
-
(2010)
Reg Toxicol Pharmacol
-
-
Teschke, R.1
Wolff, A.2
-
8
-
-
56349138698
-
Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases
-
Teschke R., Schwarzenboeck A., Hennermann K.H. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008, 20:1182-1193.
-
(2008)
Eur J Gastroenterol Hepatol
, vol.20
, pp. 1182-1193
-
-
Teschke, R.1
Schwarzenboeck, A.2
Hennermann, K.H.3
-
9
-
-
70350766713
-
Kava hepatotoxicity: regulatory data selection and causality assessment
-
Teschke R., Wolff A. Kava hepatotoxicity: regulatory data selection and causality assessment. Dig Liver Dis 2009, 41:891-901.
-
(2009)
Dig Liver Dis
, vol.41
, pp. 891-901
-
-
Teschke, R.1
Wolff, A.2
-
10
-
-
77956692082
-
Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment
-
Teschke R., Fuchs J., Bahre R., Genthner A., Wolff A. Kava hepatotoxicity: comparative study of two structured quantitative methods for causality assessment. J Clin Pharm Ther 2010, 35:545-563.
-
(2010)
J Clin Pharm Ther
, vol.35
, pp. 545-563
-
-
Teschke, R.1
Fuchs, J.2
Bahre, R.3
Genthner, A.4
Wolff, A.5
-
11
-
-
78349260262
-
Kava hepatotoxicity - a clinical review
-
Teschke R. Kava hepatotoxicity - a clinical review. Ann Hepatol 2010, 9:251-265.
-
(2010)
Ann Hepatol
, vol.9
, pp. 251-265
-
-
Teschke, R.1
-
12
-
-
38849103386
-
The quality of kava consumed in the South Pacific
-
Lebot V. The quality of kava consumed in the South Pacific. HerbalGram 2006, 71:34-37.
-
(2006)
HerbalGram
, vol.71
, pp. 34-37
-
-
Lebot, V.1
-
13
-
-
38849087754
-
Quality criteria for kava
-
Schmidt M. Quality criteria for kava. HerbalGram 2007, 73:45-49.
-
(2007)
HerbalGram
, vol.73
, pp. 45-49
-
-
Schmidt, M.1
-
14
-
-
78349273977
-
Kava hepatotoxicity: pathogenetic aspects and prospective considerations
-
Teschke R. Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver Int 2010, 30:1270-1279.
-
(2010)
Liver Int
, vol.30
, pp. 1270-1279
-
-
Teschke, R.1
-
15
-
-
78650637966
-
Kava: a comprehensive review of efficacy, safety, and psychopharmacology
-
Sarris J., LaPorte E., Schweitzer I. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Aust N Z J Psychiatry 2011, 45:36-44.
-
(2011)
Aust N Z J Psychiatry
, vol.45
, pp. 36-44
-
-
Sarris, J.1
LaPorte, E.2
Schweitzer, I.3
-
16
-
-
0004039221
-
-
Lippincott Williams & Wilkins, Philadelphia
-
Zimmerman H.J. Hepatotoxicity 1999, Lippincott Williams & Wilkins, Philadelphia.
-
(1999)
Hepatotoxicity
-
-
Zimmerman, H.J.1
-
17
-
-
68149157299
-
Drug-induced liver injury: what was new in 2008?
-
Liss G., Lewis J.H. Drug-induced liver injury: what was new in 2008?. Exp Opin Drug Metab Toxicol 2009, 5:843-860.
-
(2009)
Exp Opin Drug Metab Toxicol
, vol.5
, pp. 843-860
-
-
Liss, G.1
Lewis, J.H.2
-
18
-
-
77952702755
-
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method
-
Rockey D.C., Seeff L.B., Rochon J., et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010, 51:2117-2126.
-
(2010)
Hepatology
, vol.51
, pp. 2117-2126
-
-
Rockey, D.C.1
Seeff, L.B.2
Rochon, J.3
-
19
-
-
34548643763
-
The safety of kava - a regulatory perspective
-
Richardson W.N., Henderson L. The safety of kava - a regulatory perspective. Br J Clin Pharmcol 2007, 64:418-420.
-
(2007)
Br J Clin Pharmcol
, vol.64
, pp. 418-420
-
-
Richardson, W.N.1
Henderson, L.2
-
20
-
-
77949366119
-
Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessment
-
Teschke R., Bahre R. Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessment. Ann Hepatol 2009, 8:258-266.
-
(2009)
Ann Hepatol
, vol.8
, pp. 258-266
-
-
Teschke, R.1
Bahre, R.2
-
21
-
-
70449133964
-
Herbal and dietary supplement hepatotoxicity
-
Navarro V.J. Herbal and dietary supplement hepatotoxicity. Semin Liver Dis 2009, 29:373-382.
-
(2009)
Semin Liver Dis
, vol.29
, pp. 373-382
-
-
Navarro, V.J.1
-
22
-
-
55249125241
-
Kava hepatotoxicity: a European view
-
Available at: [accessed 03.09.10].
-
Teschke, R, Schwarzenboeck A, Akinci A. Kava hepatotoxicity: a European view. New Zeal Med J 2008;121:1283. Available at: [accessed 03.09.10]. http://www.nzma.org.nz/journal/121-1283/3296/.
-
(2008)
New Zeal Med J
, vol.121
, pp. 1283
-
-
Teschke, R.1
Schwarzenboeck, A.2
Akinci, A.3
-
23
-
-
79961127578
-
-
WHO (World Health Organization). Assessments of the risk of hepatotoxicity with kava products. WHO Document Production Services: Geneva, Switzerland.
-
WHO (World Health Organization). Assessments of the risk of hepatotoxicity with kava products. WHO Document Production Services: Geneva, Switzerland; 2007.
-
(2007)
-
-
-
24
-
-
40549094283
-
Efficacy of extracting solvents to chemical compounds of kava (Piper methysticum) root
-
Xuan T.D., Fukuta A.A., Wie A.C., Elzaawely A.A., Khanh T.D., Tawata S. Efficacy of extracting solvents to chemical compounds of kava (Piper methysticum) root. J Nat Med 2008, 62:188-194.
-
(2008)
J Nat Med
, vol.62
, pp. 188-194
-
-
Xuan, T.D.1
Fukuta, A.A.2
Wie, A.C.3
Elzaawely, A.A.4
Khanh, T.D.5
Tawata, S.6
-
25
-
-
84888458121
-
Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical, and clinical studies based on a review of the evidence
-
in press.
-
Teschke R, Qiu SX, Xuan TD, Lebot V. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical, and clinical studies based on a review of the evidence. Phytother Res; in press.
-
Phytother Res
-
-
Teschke, R.1
Qiu, S.X.2
Xuan, T.D.3
Lebot, V.4
-
26
-
-
56549100205
-
Causality assessment in hepatotoxicity by drugs and dietary supplements
-
Teschke R., Schwarzenboeck A., Hennermann K.H. Causality assessment in hepatotoxicity by drugs and dietary supplements. Br J Clin Pharmacol 2008, 66:758-766.
-
(2008)
Br J Clin Pharmacol
, vol.66
, pp. 758-766
-
-
Teschke, R.1
Schwarzenboeck, A.2
Hennermann, K.H.3
-
27
-
-
0032553342
-
Necrotising hepatitis after taking herbal remedies
-
[Article in German]
-
Strahl S., Ehret V., Dahm H.H., Maier K.P. Necrotising hepatitis after taking herbal remedies. Dtsch Med Wschr 1998, 123:1410-1414. [Article in German].
-
(1998)
Dtsch Med Wschr
, vol.123
, pp. 1410-1414
-
-
Strahl, S.1
Ehret, V.2
Dahm, H.H.3
Maier, K.P.4
-
28
-
-
34247135372
-
Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis
-
DiSilvestro R.A., Zhang W., DiSilvestro D.J. Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis. Food Chem Toxicol 2007, 45:1293-1300.
-
(2007)
Food Chem Toxicol
, vol.45
, pp. 1293-1300
-
-
DiSilvestro, R.A.1
Zhang, W.2
DiSilvestro, D.J.3
-
29
-
-
78349253039
-
Risk of kava hepatotoxicity and the FDA consumer advisory
-
Teschke R., Schulze J. Risk of kava hepatotoxicity and the FDA consumer advisory. J Am Med Assoc 2010, 304:2174-2175.
-
(2010)
J Am Med Assoc
, vol.304
, pp. 2174-2175
-
-
Teschke, R.1
Schulze, J.2
-
30
-
-
79251649167
-
Kava, the anxiolytic herb: back to basics to prevent liver injury?
-
Teschke R., Sarris J., Glass X., Schulze J. Kava, the anxiolytic herb: back to basics to prevent liver injury?. Br J Clin Pharmacol 2010, 10.1111/j.1365-2125.2010.03775.x.
-
(2010)
Br J Clin Pharmacol
-
-
Teschke, R.1
Sarris, J.2
Glass, X.3
Schulze, J.4
-
31
-
-
78651302770
-
Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
-
1.
-
Sarris J, Teschke R, Stough C, Scholey A, Schweitzer I. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward? Planta Med 2010;1. http://dx.doi.org/10.1055/s-0030-1250290.
-
(2010)
Planta Med
-
-
Sarris, J.1
Teschke, R.2
Stough, C.3
Scholey, A.4
Schweitzer, I.5
-
32
-
-
78651346028
-
Kava hepatotoxicity solution: a six-point plan for new kava standardization
-
Teschke R., Sarris J., Lebot V. Kava hepatotoxicity solution: a six-point plan for new kava standardization. Phytomedicine 2011, 18:96-103.
-
(2011)
Phytomedicine
, vol.18
, pp. 96-103
-
-
Teschke, R.1
Sarris, J.2
Lebot, V.3
-
33
-
-
67349168679
-
Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures
-
Teschke R., Genthner A., Wolff A. Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures. J Ethnopharmacol 2009, 123:378-384.
-
(2009)
J Ethnopharmacol
, vol.123
, pp. 378-384
-
-
Teschke, R.1
Genthner, A.2
Wolff, A.3
-
34
-
-
0037989908
-
Piperidine alkaloids from Piper methysticum
-
Dragull K., Yoshida W.Y., Tang C.S. Piperidine alkaloids from Piper methysticum. Phytochem 2003, 63:193-198.
-
(2003)
Phytochem
, vol.63
, pp. 193-198
-
-
Dragull, K.1
Yoshida, W.Y.2
Tang, C.S.3
-
35
-
-
0026728263
-
Kava: an overview
-
Singh Y.H. Kava: an overview. J Ethnopharmacol 1992, 37:13-45.
-
(1992)
J Ethnopharmacol
, vol.37
, pp. 13-45
-
-
Singh, Y.H.1
-
36
-
-
37349091412
-
Hepatocellular toxicity of kava leaf and root extracts
-
Lüde S., Török M., Dieterle S., Jäggi R., Büter K.B., Krähenbühl S. Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine 2008, 15:120-131.
-
(2008)
Phytomedicine
, vol.15
, pp. 120-131
-
-
Lüde, S.1
Török, M.2
Dieterle, S.3
Jäggi, R.4
Büter, K.B.5
Krähenbühl, S.6
-
37
-
-
84888461618
-
Pipermethystine, an alkaloid from kava stem peelings, induces liver cell death via GSH depletion and modulation of MAPK and NF-κB signaling pathways
-
in press.
-
Qiu SX, Dagull K, Liu JH, et al. Pipermethystine, an alkaloid from kava stem peelings, induces liver cell death via GSH depletion and modulation of MAPK and NF-κB signaling pathways. Chem Res Toxicol; in press.
-
Chem Res Toxicol
-
-
Qiu, S.X.1
Dagull, K.2
Liu, J.H.3
-
38
-
-
84888453025
-
-
SPC Report. Pacific kava: a producer's guide. Secretariat of the Pacific Community; 2001. Suva, Fiji Islands. ISBN 982-203r-r810-0.
-
SPC Report. Pacific kava: a producer's guide. Secretariat of the Pacific Community; 2001. Suva, Fiji Islands. ISBN 982-203r-r810-0.
-
-
-
-
39
-
-
38849086101
-
Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products?
-
Lechtenberg M., Quandt B., Schmidt M., Nahrstedt A. Is the alkaloid pipermethystine connected with the claimed liver toxicity of kava products?. Pharmazie 2008, 63:71-74.
-
(2008)
Pharmazie
, vol.63
, pp. 71-74
-
-
Lechtenberg, M.1
Quandt, B.2
Schmidt, M.3
Nahrstedt, A.4
-
40
-
-
2442710270
-
In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones
-
Nerurkar P.V., Dragull K., Tang C.S. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Toxicol Sci 2004, 79:106-111.
-
(2004)
Toxicol Sci
, vol.79
, pp. 106-111
-
-
Nerurkar, P.V.1
Dragull, K.2
Tang, C.S.3
-
41
-
-
34548636945
-
A re-evaluation of kava (Piper methysticum)
-
Ernst E. A re-evaluation of kava (Piper methysticum). Br J Clin Pharmacol 2007, 64:415-417.
-
(2007)
Br J Clin Pharmacol
, vol.64
, pp. 415-417
-
-
Ernst, E.1
-
42
-
-
34347232391
-
Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats
-
Lim S.T., Dragull K., Tang C.S., Bittenbender H.C., Efird J.T., Nerurkar P.V. Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats. Toxicol Sci 2007, 97:214-221.
-
(2007)
Toxicol Sci
, vol.97
, pp. 214-221
-
-
Lim, S.T.1
Dragull, K.2
Tang, C.S.3
Bittenbender, H.C.4
Efird, J.T.5
Nerurkar, P.V.6
-
43
-
-
33646500546
-
In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum)
-
Jhoo J.W., Freeman J.P., Heinze T.M., et al. In vitro cytotoxicity of nonpolar constituents from different parts of kava plant (Piper methysticum). J Agric Food Chem 2006, 54:3157-3162.
-
(2006)
J Agric Food Chem
, vol.54
, pp. 3157-3162
-
-
Jhoo, J.W.1
Freeman, J.P.2
Heinze, T.M.3
-
44
-
-
78349302551
-
The hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress trough modulation of IKK/NF-κB and MAPK signaling pathways
-
Zhou P., Gross S., Liu J.H., et al. the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress trough modulation of IKK/NF-κB and MAPK signaling pathways. FASEB J 2010, 24:4722-4732.
-
(2010)
FASEB J
, vol.24
, pp. 4722-4732
-
-
Zhou, P.1
Gross, S.2
Liu, J.H.3
-
45
-
-
0036183953
-
Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots
-
Wu D., Yu L., Nair M.G., DeWitt D.L., Ramsewak R.S. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots. Phytomedicine 2002, 9:41-47.
-
(2002)
Phytomedicine
, vol.9
, pp. 41-47
-
-
Wu, D.1
Yu, L.2
Nair, M.G.3
DeWitt, D.L.4
Ramsewak, R.S.5
-
46
-
-
84888460842
-
-
Vanuatu Legislation: kava Act 2002. Available at: [accessed 30.11.10].
-
Vanuatu Legislation: kava Act 2002. Available at: [accessed 30.11.10]. http://www.paclii.org/vu/legis/num_act/toc-K.html.
-
-
-
-
47
-
-
40449086665
-
Dose translation from animal to human studies revisited
-
Reagan-Shaw S., Nihal M., Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008, 22:659-661.
-
(2008)
FASEB J
, vol.22
, pp. 659-661
-
-
Reagan-Shaw, S.1
Nihal, M.2
Ahmad, N.3
-
48
-
-
70449493312
-
Rapid identification of bacterial isolates from aqueous kava (Piper methysticum) extracts by polymerase chain reaction and DNA sequencing
-
Kandukuru P., Huang A.S., Dong J., Bittenbender H.C., Li Y. Rapid identification of bacterial isolates from aqueous kava (Piper methysticum) extracts by polymerase chain reaction and DNA sequencing. Appl Microbiol 2009, 49:764-768.
-
(2009)
Appl Microbiol
, vol.49
, pp. 764-768
-
-
Kandukuru, P.1
Huang, A.S.2
Dong, J.3
Bittenbender, H.C.4
Li, Y.5
-
49
-
-
33750687298
-
Determination of aflatoxins and ochratoxin A in ginseng and other botanical roots by immunoaffinity column cleanup and liquid chromatography with fluorescence detection
-
Trucksess M., Weaver C., Oles C., D'Ovidio K., Rader J. Determination of aflatoxins and ochratoxin A in ginseng and other botanical roots by immunoaffinity column cleanup and liquid chromatography with fluorescence detection. J AOAC Int 2006, 89:624-630.
-
(2006)
J AOAC Int
, vol.89
, pp. 624-630
-
-
Trucksess, M.1
Weaver, C.2
Oles, C.3
D'Ovidio, K.4
Rader, J.5
-
50
-
-
77949924657
-
Determination of aflatoxins in botanical roots by a modification of AOAC Official Method 991.31: single-laboratory validation
-
Weaver C.M., Trucksess M.W. Determination of aflatoxins in botanical roots by a modification of AOAC Official Method 991.31: single-laboratory validation. J AOAC Int 2010, 93:184-189.
-
(2010)
J AOAC Int
, vol.93
, pp. 184-189
-
-
Weaver, C.M.1
Trucksess, M.W.2
-
51
-
-
0016709916
-
Hepatitis due to aflatoxicosis. An outbreak in Western India
-
Krishnamachari K.A., Bhat R.V., Nagarajan V., Tilak T.B. Hepatitis due to aflatoxicosis. An outbreak in Western India. Lancet 1975, 7915:1061-1063.
-
(1975)
Lancet
, vol.7915
, pp. 1061-1063
-
-
Krishnamachari, K.A.1
Bhat, R.V.2
Nagarajan, V.3
Tilak, T.B.4
-
52
-
-
0018194503
-
Epidemic of toxic hepatitis in India of possible mycotoxic origin
-
Tandon H.D., Tandon B.N., Ramalingaswami V. Epidemic of toxic hepatitis in India of possible mycotoxic origin. Arch Pathol Lab Med 1978, 102:372-376.
-
(1978)
Arch Pathol Lab Med
, vol.102
, pp. 372-376
-
-
Tandon, H.D.1
Tandon, B.N.2
Ramalingaswami, V.3
-
53
-
-
0020050010
-
Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya
-
Ngindu A., Johnson B.K., Ngira J.A., et al. Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya. Lancet 1982, 319:1346-1348.
-
(1982)
Lancet
, vol.319
, pp. 1346-1348
-
-
Ngindu, A.1
Johnson, B.K.2
Ngira, J.A.3
-
54
-
-
0001013981
-
The origin and distribution of kava (Piper methysticum Forst. F. Piperaceae): a phytochemical approach
-
Lebot V., Lévesque J. The origin and distribution of kava (Piper methysticum Forst. F. Piperaceae): a phytochemical approach. Allertonia 1989, 5:223-281.
-
(1989)
Allertonia
, vol.5
, pp. 223-281
-
-
Lebot, V.1
Lévesque, J.2
-
55
-
-
0030236850
-
Genetic control of kavalactone chemotypes in Piper methysticum cultivars
-
Lebot V., Lévesque J. Genetic control of kavalactone chemotypes in Piper methysticum cultivars. Phytochemistry 1996, 43:397-403.
-
(1996)
Phytochemistry
, vol.43
, pp. 397-403
-
-
Lebot, V.1
Lévesque, J.2
-
56
-
-
0003553395
-
-
Yale University Press, New Haven
-
Lebot V., Merlin M., Lindstrom L. Kava, the Pacific elixir 1997, Yale University Press, New Haven.
-
(1997)
Kava, the Pacific elixir
-
-
Lebot, V.1
Merlin, M.2
Lindstrom, L.3
-
57
-
-
0033385371
-
Morphological, phytochemical and genetic variation in Hawaiian cultivars of 'Awa (Kava, Piper methysticum, Piperaceae)
-
Lebot V., Johnston E., Zheng Q.Y., McKern D., McKenna D. Morphological, phytochemical and genetic variation in Hawaiian cultivars of 'Awa (Kava, Piper methysticum, Piperaceae). Econ Bot 1999, 53:407-418.
-
(1999)
Econ Bot
, vol.53
, pp. 407-418
-
-
Lebot, V.1
Johnston, E.2
Zheng, Q.Y.3
McKern, D.4
McKenna, D.5
-
58
-
-
47849099259
-
Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu
-
Lasme P., Davrieux F., Montet D., Lebot V. Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu. J Agric Food Chem 2008, 56:4976-4981.
-
(2008)
J Agric Food Chem
, vol.56
, pp. 4976-4981
-
-
Lasme, P.1
Davrieux, F.2
Montet, D.3
Lebot, V.4
-
59
-
-
70350123076
-
Kava and St. John's wort: current evidence for use in mood and anxiety disorders
-
Sarris J., Kavanagh D.J. Kava and St. John's wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med 2009, 15:827-836.
-
(2009)
J Altern Complement Med
, vol.15
, pp. 827-836
-
-
Sarris, J.1
Kavanagh, D.J.2
-
60
-
-
67651005824
-
The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum
-
Sarris J., Kavanagh D.J., Byrne G., Bone K.M., Adams J., Deed G. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum. Psychopharmacology 2009, 205:399-407.
-
(2009)
Psychopharmacology
, vol.205
, pp. 399-407
-
-
Sarris, J.1
Kavanagh, D.J.2
Byrne, G.3
Bone, K.M.4
Adams, J.5
Deed, G.6
-
61
-
-
0036046724
-
Kava extract for treating anxiety (Cochrane Review)
-
Wiley Interscience. doi:10.1002/14651858.
-
Pittler MH, Ernst E. Kava extract for treating anxiety (Cochrane Review). Cochrane Database Syst Rev 2003;(1):CD003383. Wiley Interscience. doi:10.1002/14651858.
-
(2003)
Cochrane Database Syst Rev
, Issue.1
-
-
Pittler, M.H.1
Ernst, E.2
|